Agios Pharma(CH:8AP)
CH:8AP
Agios Pharma earnings date
Agios Pharma (8AP) Q3 2024 Earnings Report
1 Followers
CH:8AP Q3 2024 EPS Results
- Actual EPS
- CHF 13.60
- Consensus EPS
- CHF 12.76
- Beat/Miss
- Beat by +CHF 0.84
- One Year Ago EPS
- -CHF 1.38
CH:8AP Q3 2024 Revenue Results
- Actual Revenue
- CHF 7.52M
- Expected Revenue
- CHF 7.92M
- Beat/Miss
- Missed by -CHF 397.55K
- YoY Revenue Growth
- +21.15%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 10/31/2024
- Time
- Before Open
- Conference Call
- Thursday, October 31, 2024
CH:8AP Upcoming Earnings
Agios Pharma's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q3 2024 Earnings Call Audio
CH:8AP Q3 2024 Earnings Call
0:00 / 0:00
Q3 2024 Earnings Slide Deck
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:8AP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.93- | -1.56 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -1.04-0.91 | -1.49 | 38.76% (+0.58) | |
| Jul 30, 2026 | 2026 (Q2) | -1.39-1.42 | -1.62 | 12.44% (+0.20) | |
| Apr 29, 2026 | 2026 (Q1) | -1.51-1.42 | -1.3 | -9.03% (-0.12) | |
| Feb 12, 2026 | 2025 (Q4) | -1.64-1.56 | -1.21 | -29.17% (-0.35) | |
| Oct 30, 2025 | 2025 (Q3) | -1.59-1.49 | 13.6 | -110.97% (-15.10) | |
| Jul 31, 2025 | 2025 (Q2) | -1.52-1.62 | -1.42 | -14.20% (-0.20) | |
| May 01, 2025 | 2025 (Q1) | -1.49-1.30 | -1.22 | -6.90% (-0.08) | |
| Feb 13, 2025 | 2024 (Q4) | -1.42-1.21 | -1.43 | 15.79% (+0.23) | |
| Oct 31, 2024 | 2024 (Q3) | 12.7613.60 | -1.38 | 1089.02% (+14.98) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
